Please do not leave this page until complete. This can take a few moments.
Westborough’s Kopin Corp., a manufacturer of wearable technology, has announced a partnership with San Diego-based HMDmd, Inc. to develop a head-worn display system for surgeons to ease their access to video information during surgery.
Marlborough’s Scitara Co. announced today it has closed $5 million in a Series A round of funding.
When Matt Zicaro joined forces with Michael O’Brien of Galaxy Development, they launched a new development firm – Galaxy Life Sciences – committed to building out the bioscience industry in Central Massachusetts.
Definitive Healthcare, a fast-growing Framingham healthcare data and analytics firm, has signed a lease for 56,000 square feet of additional office space it's now renovating.
IT managed services provider AKUITY Technologies, of Auburn, has been acquired by ICS of New York, the businesses announced on Thursday.
Diagnostic company Oxford Immunotec, which has U.S. headquarters in Marlborough, will be acquired by Waltham-based PerkinElmer for $591 million, the companies announced Thursday morning.
The Southborough firm Trivedi Advanced Technologies is moving into a far larger office about two and a half miles away as part of an ambitious growth plan.
Already with several big wins in 2020, the region’s biotech industry will take advantage of an even bigger boom.
Robert Coughlin, who announced his impending resignation as CEO of Cambridge life sciences trade association MassBio on Monday, is leaving his post to become managing director of real estate company JLL’s life sciences sector.
MassBio, a Cambridge nonprofit trade association representing the Massachusetts life science industry, will begin a nationwide search for a new CEO following its current president and CEO’s departure in early 2021.
Framingham-based Trilio, a provider of data protection for cloud-native environments, has secured $15 million in funding.
Cinch I.T., a Worcester-based information technology firm, is planning up to 12 new locations across the country next year as the need for remote tech support has ballooned during the coronavirus pandemic.
California’s Revance Therapeutics has secured a tax increment financing agreement with Marlborough to cover a planned $115-million new construction with the company committing to the creation of 76 jobs.
Information technology company Virtusa, based in Southborough, received a boost to its plans for a $2-billion acquisition by financial services firm Baring Private Equity Asia with a independent advisory firms recommending stockholders vote for the
Marlborough drugmaker Phio Pharmaceuticals has ended the third quarter of the year with $16.9 million on hand as it ramps up its research and development of its cancer therapy technology.
Framingham biotech company Arch Therapeutics has raised $1.1 million from long-term shareholders, the company announced on Tuesday.